Pierce1, a novel p53 target gene contributing to the ultraviolet-induced DNA damage response

Cancer Research

Volumn 70, Issue 24, 2010, Pages 10454-10463

  Sung, Young Hoon ^a   Kim, Hye Jin ^a   Devkota, Sushil ^a   Roh, Jusik ^a   Lee, Jaehoon ^a,b   Rhee, Kunsoo ^c   Bahk, Young Yil ^a   Lee, Han Woong ^a  

^a Yonsei University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PIERCE1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOTOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN STABILITY; SIGNAL TRANSDUCTION; ULTRAVIOLET C RADIATION; ULTRAVIOLET RADIATION; UPREGULATION; WILD TYPE;

ANIMALS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; E2F1 TRANSCRIPTION FACTOR; FIBROBLASTS; GENE EXPRESSION REGULATION; GENES, P16; GENES, P53; GENES, RETINOBLASTOMA; HUMANS; MICE; MICE, KNOCKOUT; NIH 3T3 CELLS; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; TRANSFECTION; ULTRAVIOLET RAYS;

EID: 78650396117     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-0031     Document Type: Article

References (49)

1. Sherr CJ. The Ink4a/Arf network in tumor suppression. Nat Rev Mol Cell Biol 2001;2:731-9.
2. Quelle DE, Zyndy F, Ashmun RA, et al. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995;83:993-1000.
3. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-7.
4. Weber JD, Taylor LJ, Roussel MF, et al. Nuclear Arf sequesters Mdm2 and activates p53. Nat Cell Biol 1999;1:20-6.
5. ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J 1999;18:22-7.
6. Zindy F, Eischen CM, Randle DH, et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev 1998;12:2424-33.
7. ARF links the tumor suppressors RB and p53. Nature 1998;395:124-5.
8. Tsai KY, Hu Y, Kay F, et al. Mutation of E2f1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol Cell 1998;2:293-304.
9. Pan H, Yin C, Dyson NJ, et al. Key roles for E2f1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol Cell 1998;2:283-92.
10. Ziebold U, Reza T, Caron A, et al. E2f3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos. Genes Dev 2001;15:386-91.
11. Lane DP. p53, guardian of the genome. Nature 1992;358:15-6.
12. Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers. Science 1991;253:49-53.
13. Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992;356:215-21.
14. Jacks T, Remington L, Williams BO, et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994;4:1-7.
15. Harris CC. p53: at the crossroads of molecular carcinogenesis and risk assessment. Science 1993;262:1980-1.
16. El-Deiry WS, Kern SE, Pietenpol JA, et al. Definition of a consensus binding site for p53. Nat Genet 1992;1:45-9.
17. McLure KG, Lee PW. How p53 binds DNA as a tetramer. EMBO J 1998;17:3342-50.
18. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408:307-10.
19. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000;408:433-9.
20. Cimprich KA, Cortez D. ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol 2008;9:616-27.
21. Helt CE, Cliby WA, Keng PC, et al. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage. J Biol Chem 2005;280:1186-92.
22. Sung YH, Kim HJ, Lee HW. Identification of a novel Rb-regulated gene associated with the cell cycle. Mol Cells 2007;24:409-15.
23. Field SJ, Tsai FY, Kuo F, et al. E2F-1 Functions in mice to promote apoptosis and suppress proliferation. Cell 1996;85:549-61.
24. Jacks T, Fazeli A, Schmitt EM, et al. Effects of an Rb mutation in the mouse. Nature 1992;359:295-300.
25. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 1995;82:675-84.
26. Tsunoda T, Takagi T. Estimating transcription factor bindability on DNA. Bioinformatics 1999;15:622-30.
27. Oh W, Lee EW, Sung YH, et al. Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2. J Biol Chem 2006;281:17457-65.
28. Naviaux RK, Costanzi E, Haas M, Verma IM. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol 1996;70:5701-5.
29. Harlow E, Lane D. Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY; 1988.
30. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-25.
31. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998;92:713-23.
32. Serrano M, Lee H, Chin L, et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996;85:27-37.
33. Brugarolas J, Bronson RT, Jacks T. p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells. J Cell Biol 1998;141:503-14.
34. Hande KR. Clinical applications of anticancer drugs targeted to topoisomerase II. Biochim Biophys Acta 1998;1400:173-84.
35. Francis MA, Rainbow AJ. Role for retinoblastoma protein family members in UV-enhanced expression from the human cytomegalovirus immediate early promoters. Photochem Photobiol 2003;77:621-7.
36. Friedel AM, Pike BL, Gasser SM. ATR/Mec1: coordinating fork stability and repair. Curr Opin Cell Biol 2009;21:237-44.
37. Sarkaria JN, Busby EC, Tibbetts RS, et al. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 1999;59:4375-82.
38. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002;2:594-604.
39. Stambolic V, MacPherson D, Sas D, et al. Regulation of PTEN transcription by p53. Mol Cell 2001;8:317-25.
40. Ming M, Han W, Maddox J, et al. UVB-induced ERK/AKT-dependent PTEN suppression promotes survival of epidermal keratinocytes. 2009. [Epub ahead of print] .
41. Harrington EA, Bruce JL, Harlow E, et al. pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc Natl Acad Sci USA 1998;95:11945-50.
42. Attardi LD, de Vries A, Jacks T. Activation of the p53-dependent G1 checkpoint response in mouse embryo fibroblasts depends on the specific DNA damage inducer. Oncogene 2004;23:973-80.
43. Lan Z, Sever-Chroneos Z, Strobeck MW, et al. DNA damage invokes mismatch repair-dependent cyclin D1 attenuation and retinoblastoma signaling pathways to inhibit CDK2. J Biol Chem 2002;277:8372-81.
44. Sage J, Mulligan GJ, Attardi LD, et al. Targeted disruption of the three Rb-related genes leads to loss of G1 control and immortalization. Genes Dev 2000;14:3037-50.
45. Knudsen KE, Booth D, Naderi S, et al. RB-dependent S-phase response to DNA damage. Mol Cell Biol 2000;20:7751-63.
46. Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 2004;4:793-805.
47. Kolodner RD, Marsischky GT. Eukaryotic DNA mismatch repair. Curr Opin Genet Dev 1999;9:89-96.
48. Luo Y, Lin FT, Lin WC. ATM-mediated stabilization of hMutL DNA mismatch repair proteins augments p53 activation during DNA damage. Mol Cell Biol 2004;24:6430-44.
49. Polyak K, Waldman T, He TC, et al. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 1996;10:1945-52.